Drug Trial Radar · NCT02098473
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
Last checked: Nov 19, 2026Latest source record: May 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Aug 31, 2014
Primary completion
Feb 17, 2016
Study completion Jan 30, 2017
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Mar 28, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effective dose(s) of RPC4046 in the treatment of Eosinophilic Esophagitis (EoE). This trial consists of two phases: 16 weeks of double-blind treatment and 52 weeks of open-label extension.
Conditions
- Eosinophilic Esophagitis
Interventions
RPC4046Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Eosinophil CountTime frame: Week 16
Locations
30 sites in 3 countries. Site status is shown where the registry gives one.
Mayo Clinic - Arizona
Scottsdale, Arizona
Desert Sun Clinical Research, LLC
Tucson, Arizona
Alliance Clinical Research
Oceanside, California
Precision Research Institute, LLC
San Diego, California
University of Colorado School of Medicine
Aurora, Colorado
Connecticut Clinical Research Foundation
Bristol, Connecticut
University of Florida
Gainesville, Florida
Borland-Groover Clinic
Jacksonville, Florida
Children's Center for Digestive Healthcare
Atlanta, Georgia
Grand Teton Research Group
Idaho Falls, Idaho
Northwestern University-Feinberg School of Medicine
Chicago, Illinois
Southwest Gastroenterology
Oak Lawn, Illinois
Indiana University
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Gastroenterology and Hepatology Service Walter Reed National Military Medical Center
Bethesda, Maryland
Metropolitan Gastroenterology Group Chevy Chase Clinical Research
Chevy Chase, Maryland
West Michigan Clinical Research Center Gastroenterology Associates of Western Michigan
Wyoming, Michigan
Minnesota Gastroenterology
Plymouth, Minnesota
GI Associates and Endoscopy Center-GI Clinical Research Department
Flowood, Mississippi
Darthmouth Hitchcock Medical Center
Lebanon, New Hampshire
Asheville Gastroenterology Associates, PA
Asheville, North Carolina
University of North Carolina
Chapel Hill, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Great Lakes Gastroenterology Research
Mentor, Ohio
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania
Vanderbilt University
Nashville, Tennessee
University of Utah Division of Gastroenterology
Salt Lake City, Utah
Gastrointestinal Research Group, University of Calgary Health
Calgary, Alberta, Canada
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
Swiss EoE Clinic
Olten, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.